Akebia Therapeutics (AKBA) Posts Q2 Loss of 40c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Akebia Therapeutics (AKBA) Discloses $50M ATM Offering
August 11, 2015 4:28 PM EDTAkebia Therapeutics (NASDAQ: AKBA) filed a prospectus supplement with the Securities and Exchange Commission that contemplates the sale of up to $50 million of shares of the Companys common stock, $0.00001 par value per share, from time to time in at-the-market offerings pursuant to a... More
